logo
Loading...
Addition of immune checkpoint inhibitor to standard of care chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma: a systematic review and meta-analysis
Medicine and HealthExploration of Targeted Anti-tumor Therapy

Addition of immune checkpoint inhibitor to standard of care chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma: a systematic review and meta-analysis

R. Srinivasmurthy, J. Ta, et al.

Research conducted by Ramaditya Srinivasmurthy, Jason Ta, Sharif Afifi, Taimur Khalid, Hazem Aboaid, Rishi Kumar Nanda, Daniel Thomas Jones, Kenny Do, Kevin Nguyen, Karina Fama, Sarah Aamer, Yin Mon Myat, Jo-Lawrence Bigcas, and Kyaw Zin Thein examines whether immune checkpoint inhibitors enhance standard chemoradiotherapy for locally advanced nasopharyngeal carcinoma. Across three randomized trials involving 1,022 patients, the combination significantly improved disease-control outcomes without broadly increasing chemoradiotherapy-associated toxicity, although immune-related adverse events rose and longer follow-up is needed to establish an overall survival benefit.... show more
Citation Metrics
Citations
0
Influential Citations
0
Reference Count
222

Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 22+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny